Valley fever, also known as coccidioidomycosis, affects tens of thousands of people each year in the southwestern United States. Despite its growing incidence, many people have never heard of it — and that lack of awareness can lead to delayed diagnosis and serious complications. Understanding the basics of this fungal infection is the first step toward protecting yourself and your family.
1. It Starts With a Single Breath of Dust
Valley fever is caused by inhaling microscopic fungal spores called Coccidioides. These spores live in the dry, alkaline soil of desert regions. When soil is disturbed by wind, construction, or farming, the spores become airborne. It takes only a few inhaled spores to trigger an infection. As research on occupational exposure highlights, valley fever is fundamentally a respiratory disease caused by inhaling these Coccidioides spores, and even brief exposure can pose a risk. If you live in or travel to endemic areas, wearing a mask during dust storms is a simple protective step.
2. Cases Have Increased Dramatically in Recent Years
Valley fever is not a static threat — it is growing. Studies indicate that cases in California alone rose roughly fivefold between 2001 and 2021. Research published in 2024 links this surge to climate change, which intensifies dust storms and drought conditions that help the fungus thrive. Arizona and California report the vast majority of U.S. cases. Warmer temperatures and shifting weather patterns may push the fungus into new regions. Staying aware of local health advisories is increasingly important, even outside traditional hotspots.
3. Many People Never Realize They Have It
Roughly 60 percent of people infected with Coccidioides experience no symptoms at all. Their immune systems fight off the fungus without them ever knowing. For the remaining 40 percent, symptoms often mimic the flu or a common respiratory infection. Fatigue, cough, fever, and body aches are typical early signs. Because these overlap with so many other illnesses, valley fever is frequently misdiagnosed as pneumonia or bronchitis. If you have a lingering respiratory illness after visiting the desert Southwest, ask your doctor about valley fever testing.
4. The “Grow and Blow” Cycle Fuels Outbreaks
Scientists describe the spread of Coccidioides through a pattern called “grow and blow.” Rainy periods encourage the fungus to grow deep in the soil. When dry, windy conditions return, disturbed soil releases clouds of spores into the air. A regression analysis covering 2000 to 2015 found significant links between valley fever incidence and climate variables like precipitation and temperature. This seasonal rhythm means cases tend to spike in late summer and fall. Paying attention to local weather patterns can help you anticipate higher-risk periods.
5. Certain Groups Face Higher Risk of Severe Illness
While anyone can contract valley fever, some people are more vulnerable to severe forms. Individuals with weakened immune systems face the greatest danger. This includes people living with HIV, organ transplant recipients, and those on immunosuppressive medications. Pregnant women, particularly in the third trimester, also carry elevated risk. Studies suggest that people of African American and Filipino descent may be more susceptible to disseminated disease, though researchers are still exploring why. If you fall into a higher-risk group, discuss preventive strategies with your healthcare provider before traveling to endemic areas.
6. It Can Spread Beyond the Lungs
In about one percent of cases, valley fever disseminates beyond the lungs. This means the fungal infection spreads to other parts of the body. The skin, bones, joints, and central nervous system are the most common secondary sites. Coccidioidal meningitis is the most feared complication, as it can be life-threatening without treatment. Clinical evidence notes that the geographic spread and overall incidence of coccidioidomycosis are both increasing, making awareness of severe complications more critical than ever. Early diagnosis dramatically improves outcomes for disseminated disease.
7. Diagnosis Often Requires Specific Blood Tests
Standard chest X-rays may show abnormalities, but they cannot confirm valley fever on their own. Doctors rely on blood tests that detect antibodies against Coccidioides. The two most common are the enzyme immunoassay and the immunodiffusion test. These tests measure IgM and IgG antibodies, which appear at different stages of infection. A rising antibody titer can indicate worsening disease. Because many physicians outside endemic areas are unfamiliar with these tests, patients sometimes wait weeks or months for a correct diagnosis. Being your own advocate and mentioning travel history can speed up the process.
8. Treatment Depends on the Severity
Mild valley fever often resolves on its own with rest and monitoring. Doctors typically recommend supportive care and follow-up blood tests to track the infection. Moderate to severe cases usually require antifungal medications like fluconazole or itraconazole. Treatment courses can last months or even years for disseminated disease. In rare cases of coccidioidal meningitis, lifelong antifungal therapy may be necessary. Amphotericin B is reserved for the most serious infections. Working closely with an infectious disease specialist gives patients the best chance at a full recovery.
9. There Is Currently No Vaccine
Despite decades of research, no approved vaccine exists for valley fever in humans. Scientists have explored several candidates, but the complexity of the Coccidioides fungus makes vaccine development challenging. A canine vaccine showed some early promise, which has fueled optimism for human applications. Several research teams are currently advancing new approaches, including live attenuated and subunit vaccines. Funding and awareness remain significant barriers to progress. Until a vaccine becomes available, prevention through dust avoidance and early detection remains the most effective strategy for people living in endemic regions.
10. Climate Change May Expand Its Geographic Reach
Valley fever has traditionally been confined to the arid Southwest. However, warming temperatures and changing rainfall patterns are shifting that boundary. Research suggests the fungus could eventually become established in states as far north as Washington and as far east as the central Great Plains. Soil sampling has already detected Coccidioides in areas previously considered safe. Urban expansion into desert landscapes also increases human exposure. These trends mean that healthcare providers nationwide may need to add valley fever to their diagnostic radar. Staying informed about emerging infectious disease threats is a wise move for everyone.
Valley fever is a complex and increasingly common fungal infection that deserves more public attention than it currently receives. Whether you live in the desert Southwest or simply plan to visit, understanding the risks, symptoms, and prevention strategies can make a meaningful difference. Talk to your doctor about valley fever if you develop unexplained respiratory symptoms after spending time in endemic areas.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.
